Literature DB >> 34524179

Contemporary strategies to assess and manage liver donor steatosis: a review.

Christine Tien1, Daphne Remulla1, Yong Kwon1,2, Juliet Emamaullee1,2.   

Abstract

PURPOSE OF REVIEW: Due to a persistent shortage of donor livers, attention has turned toward ways of utilizing marginal grafts, particularly those with steatosis, without incurring inferior outcomes. Here we review the evaluation and utilization of steatotic liver allografts, highlight recently published data, and discuss novel methods of graft rehabilitation. RECENT
FINDINGS: Although severe liver allograft (>60%) steatosis has been associated with inferior graft and recipient outcomes, mild (<30%) steatosis has not. There is ongoing debate regarding safe utilization of grafts with moderate (30-60%) steatosis. Presently, no established protocols for evaluating steatosis in donor candidates or utilizing such grafts exist. Liver biopsy is accepted as the gold standard technique, though noninvasive methods have shown promise in accurately predicting steatosis. More recently, machine perfusion has been shown to enhance ex situ liver function and reduce steatosis, emerging as a potential means of optimizing steatotic grafts prior to transplantation.
SUMMARY: Steatotic liver allografts constitute a large proportion of deceased donor organs. Further work is necessary to define safe upper limits for the acceptable degree of steatosis, develop standardized evaluation protocols, and establish utilization guidelines that prioritize safety. Machine perfusion has shown promise in rehabilitating steatotic grafts and offers the possibility of expanding the deceased donor pool.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34524179      PMCID: PMC8447219          DOI: 10.1097/MOT.0000000000000893

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.269


  66 in total

Review 1.  An approach to the rational use of steatotic donor livers in liver transplantation.

Authors:  M A Urena; E Moreno Gonzalez; C J Romero; F C Ruiz-Delgado; C Moreno Sanz
Journal:  Hepatogastroenterology       Date:  1999 Mar-Apr

2.  Ex situ machine perfusion as a tool to recondition steatotic donor livers: Troublesome features of fatty livers and the role of defatting therapies. A systematic review.

Authors:  Yuri L Boteon; Amanda P C S Boteon; Joseph Attard; Hynek Mergental; Darius F Mirza; Ricky H Bhogal; Simon C Afford
Journal:  Am J Transplant       Date:  2018-07-24       Impact factor: 8.086

3.  Body Mass Index and Unenhanced CT as a Predictor of Hepatic Steatosis in Potential Liver Donors.

Authors:  Gupse Adalı; Birkan Bozkurt; Özgür Ceyhan; Sadık Server; Gülen Bülbül Doğusoy; Yıldıray Yüzer; Yaman Tokat
Journal:  Transplant Proc       Date:  2019-08-08       Impact factor: 1.066

4.  The impact of postreperfusion syndrome during liver transplantation using livers with significant macrosteatosis.

Authors:  Kristopher P Croome; David D Lee; Sarah Croome; Ryan Chadha; David Livingston; Peter Abader; Andrew Paul Keaveny; C Burcin Taner
Journal:  Am J Transplant       Date:  2019-03-26       Impact factor: 8.086

5.  The reduced tolerance of rat fatty liver to ischemia reperfusion is associated with mitochondrial oxidative injury.

Authors:  Paolo Caraceni; Marco Domenicali; Gianluigi Vendemiale; Ignazio Grattagliano; Annamaria Pertosa; Bruno Nardo; Antonio Maria Morselli-Labate; Franco Trevisani; Giuseppe Palasciano; Emanuele Altomare; Mauro Bernardi
Journal:  J Surg Res       Date:  2005-04       Impact factor: 2.192

6.  Mouse livers with macrosteatosis are more susceptible to normothermic ischemic injury than those with microsteatosis.

Authors:  Nazia Selzner; Markus Selzner; Wolfram Jochum; Beatrice Amann-Vesti; Rolf Graf; Pierre-Alain Clavien
Journal:  J Hepatol       Date:  2005-09-02       Impact factor: 25.083

7.  Hypothermic Oxygenated Perfusion (HOPE) downregulates the immune response in a rat model of liver transplantation.

Authors:  Andrea Schlegel; Philipp Kron; Rolf Graf; Pierre-Alain Clavien; Philipp Dutkowski
Journal:  Ann Surg       Date:  2014-11       Impact factor: 12.969

8.  Suitability of livers for transplantation when treated by normothermic machine perfusion.

Authors:  Marc-Antoine Allard; Carlos Castro-Benitez; Katsunori Imai; Jasmijn Selten; Alexandre Lopez; Mylène Sebagh; Antoinette Lemoine; Antonio Sa Cunha; Daniel Cherqui; Denis Castaing; Eric Vibert; René Adam
Journal:  Clin Transplant       Date:  2018-05-07       Impact factor: 2.863

Review 9.  Normothermic Machine Perfusion (NMP) of the Liver as a Platform for Therapeutic Interventions during Ex-Vivo Liver Preservation: A Review.

Authors:  Fungai Dengu; Syed Hussain Abbas; Georg Ebeling; David Nasralla
Journal:  J Clin Med       Date:  2020-04-07       Impact factor: 4.241

Review 10.  Current status of imaging in nonalcoholic fatty liver disease.

Authors:  Qian Li; Manish Dhyani; Joseph R Grajo; Claude Sirlin; Anthony E Samir
Journal:  World J Hepatol       Date:  2018-08-27
View more
  1 in total

Review 1.  Not only a small liver - The pathologist's perspective in the pediatric liver transplant setting.

Authors:  Alessandro Gambella; Luca Mastracci; Chiara Caporalini; Paola Francalanci; Claudia Mescoli; Jacopo Ferro; Rita Alaggio; Federica Grillo
Journal:  Pathologica       Date:  2022-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.